Atlas Trials

Expanded Access to RXDX-105 for Cancers With RET Alterations

Clinical trial NCT03052569 · NO_LONGER_AVAILABLE

Trial details

NCT number
NCT03052569
Sponsor
Hoffmann-La Roche
Status
NO_LONGER_AVAILABLE
Study type
EXPANDED_ACCESS
Cancers With RET Alterations

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.